Opioid Free Anesthesia and Major Spine Surgery
Opioid Free Anesthesia in Major Spine Surgery: a Prospective, Double-blinded, Randomized, Controlled Trial
1 other identifier
interventional
48
1 country
1
Brief Summary
This study compares the intraoperative opioid free anesthesia approach in multilevel spine posterior instrumentation surgery to a conventional opioid-based anesthesia. Half of participants will receive opioid free anesthesia with dexmedetomidine, lidocaine and ketamine while the other half will receive opioid based anesthesia with fentanyl, remi-fentanyl and ketamine
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2018
CompletedStudy Start
First participant enrolled
January 29, 2018
CompletedFirst Posted
Study publicly available on registry
January 31, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 16, 2023
CompletedFebruary 21, 2023
February 1, 2023
5.1 years
January 16, 2018
February 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative morphine consumption
After the surgery the patient will go to the PACU (Post Anesthesia Care Unit). the patient will receive morphine if the pain score is more than 4. the total dose of morphine in mg (milligrams) will be documented. Before discharge from the PACU, the patient will have a PCA (Patient Controlled Analgesia) morphine,All attempts and given values of morphine In mg obtained from the PCA machine will be documented at 0, 1, 2, 4, 6, 12, 18, and 24 hours and every 6 hours thereafter up to 48 hours post surgery.. And the total amount of morphine in mg will be calculated for 48 hours
48 hours
Secondary Outcomes (5)
Postoperative morphine Side effects: Sedation score .
48 hours post operative.
Postoperative morphine Side effects:Respiratory depression
48 hours
Postoperative morphine Side effects: Nausea vomiting
48 hours
Postoperative morphine Side effects: Itching
48 hours
Postoperative pain score
48 hours post operative.
Study Arms (2)
Opioid based Anesthesia
ACTIVE COMPARATORGeneral anesthesia will be induced using Propofol , fentanyl , and Rocuronium . Ketamine will be administered on induction of anesthesia with the same dose to be repeated every hour. Anesthesia will be maintained with Remi-fentanyl , sevoflurane and nitrous oxide.
Opioid Free Anesthesia
ACTIVE COMPARATOR-General anesthesia will be induced using dexmedetomidine and lidocaine started 10 minutes before induction, Propofol and Rocuronium . Ketamine will be administered on induction of anesthesia with the same dose to be repeated every hour. Anesthesia will be maintained with IV infusion of dexmedetomidine , lidocaine , sevoflurane and nitrous oxide.
Interventions
Compare the opioid based anesthesia with Fentanyl and Remifentanyl to opioid free anesthesia with dexmedetomidine and lidocaine and their effect on postoperative pain.
Eligibility Criteria
You may qualify if:
- Age group: 18-80 years old
- American Society of Anesthesiologists (ASA )class I, II and III
- Elective spine posterior instrumentation surgery of at least two levels.
You may not qualify if:
- Renal, hepatic or cardiac insufficiency.
- Alcohol or drug abuse.
- Psychiatric disease.
- Allergy or contraindication to any of the study drugs.
- Inability to comprehend pain assessment or inability to use a Patient Controlled Analgesia (PCA) device.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LAU Medical Center
Beirut, Lebanon
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hanane MD
Lebanese American University/ LAU Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 16, 2018
First Posted
January 31, 2018
Study Start
January 29, 2018
Primary Completion
February 16, 2023
Study Completion
February 16, 2023
Last Updated
February 21, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share